Ekso Bionics Holdings Inc reports results for the quarter ended in September - Earnings Summary

Chronoscale

03/11/2022 21:51

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 33 cents​​ per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 24 cents per share.
    * Revenue rose 9.2% to $3.33 million from a year ago;
analysts
expected $3.58 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 33 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Ekso Bionics Holdings Inc shares had risen by 4.5% this
quarter and lost 38.5% so far this year.
    * The company reported a quarterly loss of $4.3 million.
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 09:51 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.24          -0.33          Missed
 Jun. 30 2022      -0.24          -0.23          Beat
 Mar. 31 2022      -0.41          -0.36          Beat
 Dec. 31 2021      -0.25          -0.23          Beat